A simple LC-MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients

Bioanalysis

Volumn 5, Issue 11, 2013, Pages 1397-1407

  Huang, Yong ^a   Louie, Alexander ^a   Yang, Qiyun ^a   Massenkoff, Nicholas ^a   Xu, Connie ^b   Hunt, Peter W ^c   Gee, Winnie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Westmoor High School   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; KYNURENINE; PHOSPHATE BUFFERED SALINE; TRIFLUOROACETIC ACID; TRYPTOPHAN; WATER;

ACCURACY; AMINO ACID ANALYSIS; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DILUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA; PRECIPITATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

CHROMATOGRAPHY, LIQUID; HIV; HIV INFECTIONS; HUMANS; KYNURENINE; LIMIT OF DETECTION; TANDEM MASS SPECTROMETRY; TRYPTOPHAN;

EID: 84878834956     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.74     Document Type: Article

References (32)

1. Katz JB, Muller AJ, Prendergast GC. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol. Rev. 222, 206-221(2008
2. Schroecksnadel K, Zangerle R, Bellmann-Weiler R et al. Indoleamine-2,3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection. Curr. Drug Metab. 8(3), 225-236 (2007
3. Boasso A, Shearer GM. How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr. Drug Metab. 8(3), 217-223 (2007
4. Zangerle R, Widner B, Quirchmair G et al. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Clin. Immunol. 104(3), 242-247 (2002
5. Boasso A, Vaccari M, Fuchs D et al. Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques. J. Immunol. 182(7), 4313-4320 (2009
6. Favre D, Mold J, Hunt PW et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2(32), 32-36 (2010
7. Opitz CA, Litzenburger UM, Opitz U et al.The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-d-Tryptophan upregulates IDO1 in human cancer cells. PLoS ONE 6(5), e19823 (2011
8. Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug Discov. 1(8), 609-620 (2002
9. Huengsberg M, Winer JB, Gompels M et al. Serum kynurenine-To-Tryptophan ratio increases with progressive disease in HIV-infected patients. Clin. Chem. 44(4), 858-862 (1998
10. Zhao J, Chen H, Ni P et al. Simultaneous determination of urinary tryptophan, tryptophan-related metabolites and creatinine by high performance liquid chromatography with ultraviolet and fluorimetric detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(26), 2720-2725 (2011
11. Zhen Q, Xu B, Ma L et al. Simultaneous determination of tryptophan, kynurenine and 5-hydroxytryptamine by HPLC: Application in uremic patients undergoing hemodialysis. Clin. Biochem. 44(2-3), 226-230 (2011
12. Widner B, Werner ER, Schennach H et al. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 43, 2424-2426 (1997
13. Laich A, Neurauter G, Widner B et al. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin. Chem. 48(3), 579-581 (2002
14. Zhang X, He Y, Ding M. Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(16-17), 1678-1682 (2009
15. de Jong WH, Smit R, Bakker SJ et al. Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-Tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(7), 603-609 (2009
16. Yamada K, Miyazaki T, Shibata T et al. Simultaneous measurement of tryptophan and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 867(1), 57-61 (2008
17. Zhu W, Stevens AP, Dettmer K et al. Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography-Tandem mass spectrometry. Anal. Bioanal. Chem. 401(10), 3249-3261 (2011
18. Midttun Ø, Hustad S, Ueland PM. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 23(9), 1371-1379 (2009
19. Möller M, Du Preez JL, Harvey BH. Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 898,121-129 (2012
20. Viswanathan CT, Bansal S, Booth B et al. Workshop/conference report -quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays. AAPS J. 9(1), E30-E42 (2007
21. Matuszewski BK, Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75, 3019-3030. (2003
22. Buhrmana DL, Pricea PI, Rudewicz PJ. Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-Tandem mass spectrometry: A study of ion suppression. J. Am. Soc. Mass Spectr. 7, 1099-1105 (1996
23. Thompson M, Ellison SLR, Wood R. Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC Technical Report). Pure Appl. Chem. 74(5), 835-855 (2002
24. Keil K, Hochreitter J, DiFrancesco R et al. Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: Validation and application. Ther. Drug Monit. 29(1), 103-109 (2007
25. Houghton R, Pita HC, Ward I et al. Generic approach to validation of small-molecule LC-MS/MS biomarker assays. Bioanalysis 1(8), 1365-1374 (2009
26. van de Merbel NC. Quantitative determination of endogenous compounds in biological samples using chromatographic techniques. Trends Analyt. Chem. 27(10), 924-933 (2008
27. Li W, Cohen LH. Quantitation of endogenous analytes in biofluid without a true blank matrix. Anal. Chem. 75(21), 5854-5859 (2003
28. Jemal M, Schuster A, Whigan D. Liquid chromatography-Tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: Method validation, demonstration of using a surrogate analyte and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard. Rapid Commun. Mass Spectrom. 17, 1723-1734 (2003
29. Lee JW, Devanarayan V, Barrett YC et al. Fit-for-purpose method development and validation for successful biomarker measurment. Pharm. Res. 23(2), 312-328 (2006
30. Tsikas D. A proposal for comparing methods of quantitative analysis of endogenous compounds in biological systems by using the relative lower limit of quantification (rLLOQ). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 2244-2251 (2009
31. Huang Y, Shi R, Gee W et al. Matrix effect and recovery terminology issues in regulated drug bioanalysis. Bioanalysis 4(3), 271-279. (2012
32. Clinical and Laboratory Standards Institute. EP14-A2 Evaluation of Matrix Effects; Approved Guideline (2nd Edition). Clinical and Laboratory Standards Institute, PA, USA (2005